Trial Profile
Remediation of Impaired Self-Regulation in Patients With Mild TBI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Parkinson's disease; Traumatic brain injuries
- Focus Therapeutic Use
- 03 Aug 2021 Status changed from active, no longer recruiting to completed.
- 19 Aug 2020 Planned End Date changed from 29 Jun 2020 to 30 Jun 2021.
- 19 Aug 2020 Planned primary completion date changed from 29 Jun 2020 to 30 Jun 2021.